Biblio

Found 53 results
Filters: Keyword is Pulmonary Disease, Chronic Obstructive  [Clear All Filters]
2014
D. D. Sin, The devastating power of platelets in COPD exacerbations: can aspirin save lives in COPD?, Thorax, vol. 69, no. 7, pp. 603-4, 2014.
E. A. Vucic, Chari, R., Thu, K. L., Wilson, I. M., Cotton, A. M., Kennett, J. Y., Zhang, M., Lonergan, K. M., Steiling, K., Brown, C. J., McWilliams, A., Ohtani, K., Lenburg, M. E., Sin, D. D., Spira, A., MacAulay, C. E., Lam, S., and Lam, W. L., DNA methylation is globally disrupted and associated with expression changes in chronic obstructive pulmonary disease small airways., Am J Respir Cell Mol Biol, vol. 50, no. 5, pp. 912-22, 2014.
J. A. Guenette, New insights into the pathophysiology of mild chronic obstructive pulmonary disease., Can Respir J, vol. 21, no. 1, pp. 25-7, 2014.
G. J. Criner, Connett, J. E., Aaron, S. D., Albert, R. K., Bailey, W. C., Casaburi, R., J Cooper, A. D., Curtis, J. L., Dransfield, M. T., Han, M. L. K., Make, B., Marchetti, N., Martinez, F. J., Niewoehner, D. E., Scanlon, P. D., Sciurba, F. C., Scharf, S. M., Sin, D. D., Voelker, H., Washko, G. R., Woodruff, P. G., and Lazarus, S. C., Simvastatin for the prevention of exacerbations in moderate-to-severe COPD., N Engl J Med, vol. 370, no. 23, pp. 2201-10, 2014.
P. G. Woodruff, Chatila, W., Connett, J. E., Criner, G. J., Curtis, J. L., Dransfield, M. T., Han, M. L. K., Lazarus, S. C., Marchetti, N., Rogers, T. J., Scanlon, P. D., Sin, D. D., Voelker, H., Wendt, C., and Albert, R. K., Tumour necrosis factor receptor-75 and risk of COPD exacerbation in the azithromycin trial., Eur Respir J, vol. 43, no. 1, pp. 295-8, 2014.
H. O. Coxson, Leipsic, J., Parraga, G., and Sin, D. D., Using pulmonary imaging to move chronic obstructive pulmonary disease beyond FEV1., Am J Respir Crit Care Med, vol. 190, no. 2, pp. 135-44, 2014.
2013
H. Yun Park, Churg, A., Wright, J. L., Li, Y., Tam, S., Man, S. F. Paul, Tashkin, D., Wise, R. A., Connett, J. E., and Sin, D. D., Club cell protein 16 and disease progression in chronic obstructive pulmonary disease., Am J Respir Crit Care Med, vol. 188, no. 12, pp. 1413-9, 2013.
R. C. Chin, Guenette, J. A., Cheng, S., Raghavan, N., Amornputtisathaporn, N., Cortés-Télles, A., Webb, K. A., and O'Donnell, D. E., Does the respiratory system limit exercise in mild chronic obstructive pulmonary disease?, Am J Respir Crit Care Med, vol. 187, no. 12, pp. 1315-23, 2013.
K. Steiling, van den Berge, M., Hijazi, K., Florido, R., Campbell, J., Liu, G., Xiao, J., Zhang, X., Duclos, G., Drizik, E., Si, H., Perdomo, C., Dumont, C., Coxson, H. O., Alekseyev, Y. O., Sin, D., Paré, P., Hogg, J. C., McWilliams, A., Hiemstra, P. S., Sterk, P. J., Timens, W., Chang, J. T., Sebastiani, P., O'Connor, G. T., Bild, A. H., Postma, D. S., Lam, S., Spira, A., and Lenburg, M. E., A dynamic bronchial airway gene expression signature of chronic obstructive pulmonary disease and lung function impairment., Am J Respir Crit Care Med, vol. 187, no. 9, pp. 933-42, 2013.
J. A. Guenette, Webb, K. A., and O'Donnell, D. E., Effect of fluticasone/salmeterol combination on dyspnea and respiratory mechanics in mild-to-moderate COPD., Respir Med, vol. 107, no. 5, pp. 708-16, 2013.
J. - C. Bérubé, Lamontagne, M., Couture, C., Nickle, D., Timens, W., Postma, D. S., Sin, D. D., Paré, P. D., Laviolette, M., and Bossé, Y., Genome-wide genetic ancestry measurements to predict lung function in European populations., Eur Respir J, vol. 42, no. 4, pp. 1144-7, 2013.
N. N. Hansel, Ruczinski, I., Rafaels, N., Sin, D. D., Daley, D., Malinina, A., Huang, L., Sandford, A., Murray, T., Kim, Y., Vergara, C., Heckbert, S. R., Psaty, B. M., Li, G., W Elliott, M., Aminuddin, F., Dupuis, J., O'Connor, G. T., Doheny, K., Scott, A. F., H Boezen, M., Postma, D. S., Smolonska, J., Zanen, P., Hoesein, F. A. Mohamed, de Koning, H. J., Crystal, R. G., Tanaka, T., Ferrucci, L., Silverman, E., Wan, E., Vestbo, J., Lomas, D. A., Connett, J., Wise, R. A., Neptune, E. R., Mathias, R. A., Paré, P. D., Beaty, T. H., and Barnes, K. C., Genome-wide study identifies two loci associated with lung function decline in mild to moderate COPD., Hum Genet, vol. 132, no. 1, pp. 79-90, 2013.
J. Vestbo, Hurd, S. S., Agustí, A. G., Jones, P. W., Vogelmeier, C., Anzueto, A., Barnes, P. J., Fabbri, L. M., Martinez, F. J., Nishimura, M., Stockley, R. A., Sin, D. D., and Rodriguez-Roisin, R., Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary., Am J Respir Crit Care Med, vol. 187, no. 4, pp. 347-65, 2013.
H. A. Gietema, Edwards, L. D., Coxson, H. O., and Bakke, P. S., Impact of emphysema and airway wall thickness on quality of life in smoking-related COPD., Respir Med, vol. 107, no. 8, pp. 1201-9, 2013.
F. Aminuddin, Hackett, T. - L., Stefanowicz, D., Saferali, A., Paré, P. D., Gulsvik, A., Bakke, P., Cho, M. H., Litonjua, A., Lomas, D. A., Anderson, W. H., Beaty, T. H., Silverman, E. K., and Sandford, A. J., Nitric oxide synthase polymorphisms, gene expression and lung function in chronic obstructive pulmonary disease., BMC Pulm Med, vol. 13, p. 64, 2013.
H. O. Coxson, Dirksen, A., Edwards, L. D., Yates, J. C., Agusti, A., Bakke, P., Calverley, P. Ma, Celli, B., Crim, C., Duvoix, A., Fauerbach, P. Nasute, Lomas, D. A., MacNee, W., Mayer, R. J., Miller, B. E., Müller, N. L., Rennard, S. I., Silverman, E. K., Tal-Singer, R., Wouters, E. Fm, and Vestbo, J., The presence and progression of emphysema in COPD as determined by CT scanning and biomarker expression: a prospective analysis from the ECLIPSE study., Lancet Respir Med, vol. 1, no. 2, pp. 129-36, 2013.
H. Yun Park, Man, S. F. Paul, Tashkin, D., Wise, R. A., Connett, J. E., Anthonisen, N. A., and Sin, D. D., The relation of serum myeloperoxidase to disease progression and mortality in patients with chronic obstructive pulmonary disease (COPD)., PLoS One, vol. 8, no. 4, p. e61315, 2013.
M. Kirby, Owrangi, A., Svenningsen, S., Wheatley, A., Coxson, H. O., Paterson, N. A. M., McCormack, D. G., and Parraga, G., On the role of abnormal DL(CO) in ex-smokers without airflow limitation: symptoms, exercise capacity and hyperpolarised helium-3 MRI., Thorax, vol. 68, no. 8, pp. 752-9, 2013.
D. D. Sin and Park, H. Yun, Steroids for treatment of COPD exacerbations: less is clearly more., JAMA, vol. 309, no. 21, pp. 2272-3, 2013.
P. G. Camp, Zhang, T., M Smith, A., and Carleton, B. C., The use of long-acting β2- agonists as monotherapy in children and adults., J Popul Ther Clin Pharmacol, vol. 20, no. 1, pp. e1-12, 2013.